PHARMACYTE BIOTECH, INC.
Climate Impact & Sustainability Data (2009, July 31, 2023)
Reporting Period: 2009
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Acquisition of Freedom2 Holdings, Inc. requiring substantial review of prior filings and preparation of new disclosure related to the post-acquisition combined business enterprise.
- Undisclosed information regarding previously issued preferred stock.
Mitigation Strategies
- Undertaking a substantial review of prior filings and preparing significantly new disclosure related to the post-acquisition combined business enterprise.
- Intending to disclose information regarding preferred stock in Form 10-K and amend prior filings if necessary.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: July 31, 2023
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- The compilation, dissemination and review of the information required to be presented in the Form 10-Q for the relevant period has imposed time constraints that have rendered timely filing of the Form 10-Q impracticable without undue hardship and expense to the registrant.
Mitigation Strategies
- The registrant undertakes the responsibility to file such report no later than five days after its original prescribed due date.